Since peritoneal dialysis was introduced as a common therapeutic method it has been used as an increasing popular alternative to hemodialysis. Major drawbacks, however, are frequent complications such as infections and ultrafiltration failure that occur as a result of repeated injury to the peritoneal membrane. A crucial role in maintaining the integrity of the peritoneum is attributed to peritoneal mesothelial cells (MsC), which have been studied over the past years with regard to their response to various toxic stimuli [1] . Maintenance of an osmotic gradient across the peritoneum is crucial for ultrafiltration. Despite the known toxic effects of high glucose on MsC [2] , it is most commonly used to generate this osmotic gradient. Model systems of peritoneal membranes reveal a substantial gradient in glucose concentration across this membrane. While this gradient is only partially maintained by the MsC monolayer the primary route of glucose absorption is intercellular. Nevertheless, this gradient is significantly correlated with mesothelial cell integrety. Furthermore, mesothelial cell uptake of glucose will influence intracellular events and may contribute to the pathophysiology of glucoseinduced mesothelial injury. Although the net glucose shift during peritoneal dialysis has been studied extensively [3] , cellular facilitative glucose uptake in MsC has only recently been examined [4] . Mechanisms of active Na(ϩ)/glucose cotransport have not been studied previously.
To elucidate physiological and pathophysiological effects of intraperitoneal glucose and investigate the role of glucose transporters as a potential link to MsC injury, knowledge of the molecular mechanisms of cellular glucose transport is essential. Glucose transporters in mammalian cells belong to a large family of membrane proteins that is divided into two classes and types of genes: the SGLT1 gene encodes for the Na(ϩ)/glucose cotransporter [5] , and the GLUT genes for facilitative transporters [6] . Glucose transport in nonepithelial mammalian tissues occurs by facilitated diffusion mediated by one family of glucose transporters. To date six different transporter isoforms of the facilitative diffusion type, encoded by distinct genes, denoted GLUT1 through GLUT5 and GLUT7, have been characterized [7] . The expression of SGLT is restricted to specialized cells of the small intestine, proximal tubules of the kidney and as recently reported, to the mesangial cells [8] . The expression of SGLT1 on the apical surface in addition to GLUT on the basolateral surface of these cells allows them to perform concentrative uptake from the lumen as well as transcellular transport of glucose [5] . SGLT1 was also implicated as one means of water transport across epithelial membranes [9] . From other cell lines, such as LLC-PK 1 cells, it is known that the expression of SGLT1 and facilitative transporters varies with the degree of differentiation [10 -12] . Caution is therefore required when relying on cultured MsC to address questions that are highly dependent on the presence of differentiated cells.
Based on the common developmental origin along with similar ultrastructural and functional characteristics of MsC and pneumocytes type II that also possess Na(ϩ)/glucose cotransport, all potential means of glucose transport in MsC are of interest [13, 14] . We have investigated the expression of each of these facilitative transporters, that is, GLUT1 to GLUT4, and Na(ϩ)-dependent glucose transport, that is, SGLT1. To achieve different states of cell differentiation, experiments were performed on regular cell cultures and cells after induction of cell differentiation.
METHODS

Cell culture, characterization and differentiation
Primary MsC were obtained, prepared and cultured as described [15] . A transfected human peritoneal mesothelial cell line (passages number 12-15) had been established in our laboratory previously [15] . LLC-PK 1 and CaCo-2 cells, a cell line derived from a human colon carcinoma [16] , were obtained from ATCC (Rockville, MD, USA). In brief, primary MsC, transfected MsC, LLC-PK 1 (ATCC no. 101-CL), human fibroblasts and CaCo-2 cells were cultured in DMEM with 10% bovine serum (Serum supreme; BioWhittaker, Walkersville, CA, USA), penicillin/streptomycin 100 U/100 g/liter and with additional glucose (final concentration 2000 mg/liter). In contrast to transfected MsC, the dishes for primary MsC culture had to be coated with fibronectin (Sigma, Deisenhofen, Germany). Expression of glucose transporters was induced by chemical differentiation with addition of 6 mM hexamethylene bisacetamide (HMBA) (Sigma-Aldrich, Steinheim, Germany) for seven days or culture on permeable Cyclopore membrane supports for seven days after confluence (Falcon cell culture insert; pore size 0.45 m; Stricker, Oberschlei␤heim, Germany).
Cell proliferation/toxicity assays
Metyltetrazolium dye test. Proliferation was assessed with a modified methyl-tetrazolium (MTT) dye procedure [17] . The MTT-staining (absorbance at 600 nm) for transfected MsC was found to increase linearly with the cell number from 5 ϫ 10 3 to 1.2 ϫ 10 5 cells loaded per well in a 96-well plate (data not shown). To study the effect of various agents on MsC growth, cells were seeded with 180 l medium at a density of 1 ϫ 10 4 cells per well. After 14 hours, HMBA was added to the wells at varying concentrations and incubation continued for two, six and nine days. All experiments were done in pentaplicate.
Cell count. For counting, the cells were loaded into 24-well plates at a density of 2 ϫ 10 4 cells per well. After three days, HMBA was added to the proliferating cells in different concentrations (3 mM; 6 mM). After further incubation for two, six and nine days cells were trypsinized and the cell count was determined with a Neubauer chamber and compared to the cell count without HMBA treatment.
Lactate dehydrogenase release. Transfected MsC were seeded into 24-well plates, grown to confluency and incubated for two days or six days with and without HMBA. Medium was collected and filtered prior to lactate dehydrogenase (LDH) analysis to remove any detached cells. LDH analysis was performed on an automatic analyzer (Hitachi 717; Boehringer Mannheim, Germany).
Reverse transcription and polymerase chain reaction analysis
RNA was extracted from cells grown on 35 mm dishes according to the TRI -Reagent kit protocol [18] . In brief, primary and transfected MsC were washed once with PBS, then TRI -Reagent was added to each well and the lysate frozen in liquid nitrogen. Chloroform was added to each sample and after incubation for five minutes on ice, the tubes were centrifuged at 14,000 rpm for 15 minutes. From each tube the upper phase was transferred to a new DEPC-treated tube. After repetition of the RNA isolation step for higher purification, the RNA was precipitated by isopropanol and centrifugation. RNA was reverse transcribed into cDNA with oligo(dT) (Boehringer Mannheim) and SuperScriptRT (200 U/l; Life Technologies, Eggenstein, Germany) over one hour at 42°C. Sequence-specific oligonucleotide primers (Table 1) were purchased from Life Technologies. PCR reactions were performed in a total volume of 25 l containing: 1 l of transcribed cDNA, 10ϫ PCR buffer, 2.5 U AmpliTaq , (both Perkin Elmer, Weiterstadt, Germany), 200 M of each dNTP, sense and antisense primer (10 pmol), 5 Ci of 32 P-dCTP (Amersham, Braunschweig, Germany). Samples were incubated for three minutes at 94°C, followed by 30 cycles (35 cycles for SGLT1) of 45 seconds at 94°C, one minute at 56°C and one minute at 72°C and a final extension for seven minutes at 72°C in a Perkin Elmer 9600 Thermal Cycler (Perkin Elmer, Weiterstadt, Germany). Negative controls consisting of the reaction mixture without cDNA and not reversely transcribed (RT minus) controls were included in all reaction series. The cloned cDNAs for the different glucose transporters served as positive controls. Authenticity of amplified PCR products was verified by specific restriction site analysis or, for SGLT1, by cycle sequencing on an ABI PRISM 377 automated sequencer (Perkin Elmer).
Semiquantification of the PCR product. The amplified cDNA was analyzed on 5% polyacrylamide gel in Tris-borate EDTA buffer, and visualized with ImageQuant Software on a Storm Fluorophosphorimager (both Molecular Dynamics, Krefeld, Germany). The intensities of the cDNA bands for the glucose transporters were normalized to the ␤-actin band intensities. Saturation of the PCR product was excluded using serial dilutions. The stable expression of ␤-actin mRNA regardless of the state of cell differentiation was verified with the expression of GAPDH, another housekeeping gene (data not shown).
Western immunoblotting
Cells were grown in 10 cm dishes and prepared as reported [19] . In brief, cells were washed with PBS once, then solubilized in lysis buffer (50 mM Tris-HCl, pH 8, 150 mM NaCl, 0.02% sodium azide, 100 g/ml PMSF, 1 g/ml aprotinin, 1% Triton X) and harvested. After centrifugation of the lysate at 12,000 ϫ g for two minutes at 4°C supernatants were loaded onto Laemmli minigel (7 to 10%). The separated proteins were transferred to Immobilon membranes (Millipore, Eschborn, Germany) using an electroblotting system (BioRad, München, Germany). The filters were blocked for two hours at room temperature with 5% dry milk and 0.05% Tween 20 (Flika, Buchs, Switzerland) in Tris-buffered saline and incubated with antibodies specific for GLUT1 and GLUT3 [19] (East Acres, Wak Chemie, Bad Homburg, Germany) at a concentration of 1:800 and 1:500 respectivley. Visualization of bound antibodies was carried out with the ECL system (Amersham).
Immunofluorescence
Indirect immunoflurescence was performed as previously reported [15] . In brief, cells were grown in chamber slides (Lab-Tek, Naperville, IL, USA) until complete confluency was reached, fixed in 1:1 (vol:vol) methanol/acetone, washed with PBS and TWEEN (Flika) and then incubated with the antibodies against GLUT1, GLUT3 and SGLT1 (diluted 1:40, Wak Chemie) or hyperimmune serum. After 60 minutes unbound antibodies were washed off and the cells were incubated for another 60 minutes with 50 l of a FITC-(for GLUT1 and SGLT1) or TRITC-conjugated secondary antibody (diluted 1:40 in PBS; Sigma). Specific staining was compared with negative controls that were processed with hyperimmune serum in the absence of the respective primary antibody. Immunofluorescence micrographs were obtained using a microscope (Leica DMRBE, Germany) equipped for photography (Leica DMRD, Germany) with Kodak films.
Hexose uptake determinations
Methyl(alpha-D-[U-
14 C]gluco)pyranoside (AMG) uptake. Measurements were performed as previously reported [8] . Cells were washed with 2 ml of 20 mM Tris/HEPES buffer, pH 7.4, containing 1 mmol/liter CaCl 2 , 5 mmol/liter KCl, 2,5 mmol/liter MgSO 4 and either 150 mmol/liter NaCl or 150 mmol/liter choline cloride and preincubated in 2 ml of these NaCl or choline chloride solutions for 20 minutes with or without 0.5 mM phlorizin (Sigma). For the glucose uptake experiments, the appropriate solutions were renewed and AMG (Amersham, Buckinghamshire, UK) was added, resulting in final radioactive concentrations ranging from 0.1 to 1.0 Ci (0.3 to 3 mol/liter) in an incubation volume of 1 ml per well. After incubation at 37°C for 60 minutes, cells were washed three times with 2 ml of ice-cold PBS, containing 0.5 mM phlorizin. The cells were then solubilized with 1.5 ml 0.1 M NaOH ϩ 1% SDS per dish at room temperature for two hours. 400 l were added to 3 ml of Quickszint 2000 (Zinsser Analytic, Maidenhead, UK) and radioactivity determined with a beta liquid scintillation counter (Wallac Oy, Turku, Finland) employing the ESR-methode for 14 C counting. The remaining cell lysate was used for protein measurement. For experiments with cells on filter membranes DMEM/AMG with or without phlorizin was added to the apical side of the cells for incubation but otherwise processed identically [20, 21] .
2-Fluoro-2-deoxy-[ 14 C]-D-glucose (FDG) uptake.
Cells were washed and pre-incubated for 20 minutes in 2 ml PBS each. For uptake determination, radiolabeled FDG (Amersham) with or without the uptake-inhibitors cytochalasin B (10 mol/liter) or phloretin (0.2 mmol/liter; both Sigma) [22] was added to 1 ml of this medium resulting in final concentrations of 0.33 to 1.0 Ci (1 to 3 mol/liter). After incubation at 37°C for 30 minutes, cells were washed three times with 2 ml of ice-cold PBS, containing cytochalasin B or phloretin. The cells were then solubilized and processed as in AMG uptake studies.
Na(؉)/glucose currents in mesothelial cells
To determine Na ϩ /glucose cotransport-dependent depolarization of membrane potential, transfected MsC were grown on coated glass coverslips and mounted in a superfusion chamber. Standard patch clamp techniques, in the whole-cell, current clamp mode, were applied to the apical surface of postconfluent coble stone-shaped cells. Experiments were performed at room temperature using an Axopatch 200A amplifier (Axon Instruments, Inc., Foster City, CA, USA), a Zeiss IM-35 inverted microscope with DIC optics (Zeiss, Oberkochen, Germany), and a Narishige WR-88 hydraulic micromanipulator (Narishige Scientific Instrument Laboratory, Tokyo, Japan). Recording pipettes (2 Mohm, 2 m inner tip diameter; whole cell input and series resistance usually 0.5 to 1 Gohm and 20 Mohm, respectively) were manufactured from 1. Abbreviations are: Sense (S) and antisense (AS) primer pairs specific for sodium/glucose transporter (SGLT1), facilitative glucose transporter isoforms (GLUT1-4), ␤-actin, and glycerophosphate dehydrogenase (GAPDH). Nucleotide numbers refer to positions within the published sequence.
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K 2 ATP, 0.171 CaCl 2 (10 Ϫ8 M free Ca 2ϩ ) and 10 mM HEPES (N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid, titrated to pH 7.2 with KOH). Monolayers were continously superfused using NaCl and choline chloride solutions as used for AMGuptake studies in the presence or absence of 10 mM glucose. Recorded membrane potentials were stored on a DAT tape (DTR-1204 DAT Recorder; Bio-Logic Co., Claix, France), and analyzed graphically after plotting.
Statistical analyses
Hexose uptake studies. All data are presented as the mean Ϯ SEM. The Mann-Whitney U-test (two-tailed) was used for statistical determinations and P Ͻ 0.05 was considered significant.
Na(ϩ)/glucose currents, MTT test and cell counts in MsC.
Differences between mean values were estimated by t-test or Welsh's approximation (two-tailed) using InStat (GraphPad Software, Inc., San Diego, CA, USA). P values of P Ͻ 0.05 were considered significant.
RESULTS
Cell proliferation/toxicity assay
After incubation with HMBA, MsC showed a dose dependent reduction of cell proliferation as assessed by the MTT assay (Fig.  1A ) and cell count (Fig. 1B) . Simultaneous determinations of LDH release failed to show any change (Fig. 1C) .
Identification of mRNAs for the glucose transporters
Primary as well as transfected MsC expressed GLUT1 and GLUT3 in every state of differentiation (Fig. 2) . RT-PCR detected no specific amplification product for GLUT2 and GLUT4 transcripts. Further semiquantitative RT-PCR analysis documented differentiation dependent changes for GLUT1 and SGLT1, but not for GLUT3. The addition of HMBA to confluent cultures or the growth on filters produced a down-regulation of GLUT1 mRNA and a substantial increase in SGLT1 mRNA, whereas the latter transcript was not detectable in subconfluent cells (Fig. 2) . After sequencing, the amplified 521 bp PCR-product of the intron-spanning SGLT1 oligonucleotide primer pairs presented 100% identity with the 1365-1886 nucleotide of human SGLT1 [23] . In confluent cells the expression of GLUT1 as well as SGLT1 mRNA varied considerably, probably due to asynchronous differentiation, ranging from levels seen in subconfluent cells to those seen in HMBA-treated cultures (not shown). Negative controls for the RT-PCR consisted of the reaction mixture without cDNA, not reversely transcribed (RT minus) controls and of fibroblasts. The cloned cDNAs for the different glucose transporters as well as the cDNA of CaCo-2 cells, a human colon carcinoma cell line known to express GLUT1, GLUT3 and SGLT1 [16, 24] , yielded positive results.
Western blotting
Using a specific antibody directed against GLUT1, a characteristic band of 46 kDa could be observed on Western blotting. A 46 kDa band of GLUT3 was detected only in human CaCo-2 cells, which served as a positive control for GLUT3 protein, but not in MsC (Fig. 3) [20] .
Immunofluorescence
As shown in the immunofluorescence micrographs diffuse positive staining sparing the nucleus is noticed for GLUT1 in transfected as well as primary MsC (Fig. 4A) . In transfected MsC staining for SGLT1 was positive (Fig. 4B) . Fluorescence for GLUT3 was only slightly above background in MsC and CaCo-2 cells (Fig. 4 D, E) .
Demonstration of Na(؉)-dependent ␣-methyl-D-[
C]glucopyranoside-glucose uptake
␣-Methyl-D-[
14 C]glucopyranoside (AMG) is a non-metabolizable glucose analog specific for the Na(ϩ)-dependent glucose transport [25] . Phlorizin is a competitive, non-transported inhibitor of SGLT1 [5] . In HMBA treated MsC, and in MsC grown on filters, we measured a 30 to 45% reduction of AMG uptake after addition of phlorizin. This indicated the presence of SGLT in differentiated MsC (Fig. 6A) . In HMBA-pretreated fibroblasts (SGLT1 mRNA negative) and in subconfluent, proliferating MsC, there was no phlorizin-sensitive AMG uptake. Compared to differentiated MsC, AMG uptake in HMBA-treated CaCo-2 cells was four-to sevenfold higher with an uptake inhibition of about 77% by phlorizin. HMBA-treated LLC-PK 1 cells yielded an approximately 100-to 150-fold increased intracellular activity of AMG that could be blocked by more than 99% by phlorizin (Fig.   Fig. 4 . Indirect immunofluoresence staining of transfected mesothelial cells (MsC) for GLUT1 (A), SGLT1 (B), negative control FITC (C), GLUT3 in MsC (D), negative control TRITC (E), and a positive control for GLUT3 (CaCo-2 cells, F). Cells were incubated with a primary antibody against GLUT1, GLUT3 or SGLT1 followed by staining with FITC-or TRITC-conjugated secondary antibodies as described in the Methods section. At a magnification of ϫ200 diffuse staining with sparing of the nuclei is noted. 6A). The nonphlorizin-inhibitable fraction of AMG uptake averaged 3.9 pmol/mg protein/hr and was similar in all cell types tested. When replacing Na(ϩ) by choline chloride, no effect of phlorizin on AMG uptake could be observed (Fig. 5) . These results are consistent with a Na(ϩ)-dependent phlorizin-inhibitable component of glucose uptake by MsC.
Na(؉)/glucose currents
Initial membrane potentials recorded in a NaCl bath solution were low (Ϫ15 Ϯ 1 mV, N ϭ 6). Addition of 10 mM D-glucose depolarized and subsequent removal of glucose repolarized the membrane potential to Ϫ7 Ϯ 2 mV and Ϫ12 Ϯ 2 mV, respectively, within several minutes of incubation (Fig. 7) . The addition of glucose into a medium where NaCl was replaced by choline chloride slowly hyperpolarized membrane potentials (from Ϫ14.7 Ϯ 2.5 mV to Ϫ22.7 Ϯ 2.1 mV to Ϫ25.5 Ϯ 4.1 mV, not shown), again supporting the presumed presence of a Na(ϩ)-dependent glucose transporter.
Demonstration of facilitative transport
2-Fluoro-2-deoxy-[
14 C]-D-glucose (FDG) uptake is mediated only by the facilitative transporter isoform (GLUT) and can be blocked by cytochalasin B and phloretin [22] . The uptake of FDG increased linearly both with time over a period of 60 minutes and with increasing concentrations of FDG added (data not shown). In FDG transport studies with similar absolute and specific activity as in AMG studies, 50-to 150-fold higher counts of beta activity were obtained and could be blocked by 90% by cytochalasin B (10 M; data not shown) and by 99% by phloretin (0.2 mM). The differentiation dependence of the facilitative glucose transport was demonstrated analyzing the FDG uptake of subconfluent, confluent and HMBA-treated MsC (N ϭ 3 per group) . The sugar uptake of subconfluent cells was not different from confluent MsC but was 55% higher than the uptake of HMBAtreated cells (Fig. 6B) . These findings indicate a differentiation dependent facilitative glucose transport in MsC with downregulation of glucose uptake in differentiated cultures.
DISCUSSION
This study was directed toward at a better understanding of the cellular mechanisms of glucose transport into MsC and the effects of cell differentiation thereon. We demonstrated for the first time that both facilitated and Na(ϩ)-dependent glucose transporters are present in human peritoneal MsC.
Differentiation can be induced either through the culture of MsC cells on membranes which causes polarization, or through the addition of the chemical differention inducer HMBA to confluent cultures [26] . HMBA initiates relatively synchronous differentiation compared to the slow asynchronous differentiation observed spontaneously following cell confluence [27] . We found other evidence of cell differentiation such as reduced proliferation. The addition of HMBA, not toxic below 10 mM [28] in other cell types, resulted in stable cell counts without an increase in LDH release in our model, thus strongly supporting the assumption of reduced cell proliferation without cell damage.
Growing cells and terminally differentiated cells were found to have very different profiles of glucose metabolism and uptake. Na(ϩ)-dependent glucose transport activity was not detected in dividing or in subconfluent cultures of LLC-PK 1 cells [26, 28] . In LLC-PK 1 cells the Na(ϩ)/glucose cotransport activity serves as a marker of differentiation [11] that can be achieved with HMBA, one of the most potent differentiation inducers identified to date [12, 29] . The addition of HMBA to confluent LLC-PK 1 cultures produces a substantial increase in Na(ϩ)/glucose cotransport activity [12, 28] . Our studies demonstrated regular SGLT1 mRNA expression and transport activity only in confluent primary MsC and transfected MsC after the addition of HMBA or when grown on membranes. These observations indicate that the growth of monolayers on a permeable support mimics the effects of HMBA on monolayers grown on plastic. Further evidence for Na(ϩ)-dependent glucose uptake is provided by the AMG uptake studies where the addition of phlorizin, a SGLT1 specific inhibitor, reduced glucose uptake by 30 to 45%. Compared with undifferentiated MsC where no SGLT1 mRNA and no significant phlorizin-sensitive AMG uptake was observed, this strongly supports the hypothesis of a differentiation dependent expression of SGLT1 in human peritoneal MsC, which is also consistent with the results observed in primary MsC. However, in our experiments the SGLT1 activity in MsC represents only about 20% of that in CaCo-2 cells and 1% of that in LLC-PK 1 cells, both cell types designed for Na(ϩ)-dependent glucose uptake [30] .
The identification of SGLT1 in MsC suggests the possibility of transcellular glucose transport similar to that seen in specialized epithelia such as the intestine and renal tubules [5, 31] , and appears to be of special interest in the light of a recently proposed participation of SGLT1 in transepithelial water transport [9] . Furthermore, SGLT1 may contribute to glucose uptake of MsC during peritoneal dialysis and the resulting cellular events.
The investigation of facilitative glucose transport in MsC in our studies with RT-PCR, Western blotting, immunofluorescence and FDG uptake identified GLUT1 on messenger RNA and protein level and GLUT3 on mRNA level only. This divergence may be due to the increased sensitivity of RT-PCR compared to Western blotting or immunofluorescence. The occurrence of artifacts in the RT-PCR analyses was ruled out using CaCo-2 cells as positive and fibroblasts as negative controls for the different glucose transporters. The facilitative glucose transport in MsC shows a down-regulation both in expression of GLUT1 mRNA and in FDG uptake with increasing differentiation. Although SGLT1 is up-regulated in the differentiated state, the uptake studies with radiolabeled glucose analogs show that FDG transport exceeds AMG transport despite the equimolar concentrations used and specific activities that did not differ. The relatively low expression of SGLT1 activity compared with other epithelia such as CaCo-2 cells or LLC-PK 1 cells suggests that the facilitative transporters are probably the major route of glucose uptake into MsC. In this setting the relative role of transcellular compared with intercellular glucose transport in vivo has to be considered. Therefore, the extent to which such a distinct glucose transport system influences net transport characteristics remains unclear. However, even under the assumption of exclusively intercellular glucose transport, the expression of these transporters will determine MsC uptake and may be important as a pathophysiologic link between peritoneal glucose exposure and MsC injury.
Our findings also suggest that transfected MsC can be present in various states of differentiation. Therefore, we consider transfected MsC an adequate model for the study of cellular glucose transport and dialysate toxicity, especially if a differentiated phenotype is induced through culture on membranes or pretreatment with HMBA.
The glucose transporters present in MsC, including SGLT1, GLUT1 and GLUT3, have relatively high affinities for glucose [5] , implicating that their activity is near maximum at physiologic levels of intraperitoneal/extracellular glucose concentration. This suggests that factors or conditions that affect the expression of glucose transporters on MsC could alter intracellular glucose concentration and thus affect cell function. Changes in the expression of glucose transporters in MsC may influence MsC biology and thus a number of physiological and pathophysiological processes, such as the response to intraperitoneal inflammation, regulation of matrix protein production or peritoneal fibrosis during peritoneal dialysis.
Conclusion
The identification of distinct transport systems in MsC is essential for understanding the mechanism of cellular uptake and transperitoneal glucose transport during CAPD. The present study indicates that glucose uptake by MsC is mediated by both SGLT1 and the facilitative glucose transporters. The identification of SGLT1 in differentiated MsC is not unexpected in view of their polar and epithelial nature. Further studies of the expression and possible regulation of the SGLT1 appear warranted in light of the potential role for water transport across epithelia and the cellular pathophysiology of glucose. 
